Related Experiment Video
Updated: Jul 20, 2026
An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
Published on: May 22, 2020
A novel familial MECP2 mutation in a young boy: clinical and molecular findings
P Ventura1, R Galluzzi, S M Bacca
1Department of Neurorehabilitation 2 Psychopathological Disturbances in Childhood and Adolescence, Scientific Institute Eugenio Medea for Research, Hospitalization and Healthcare, Regional Branch of Ostuni (BR), Italy.
Insights
A novel mutation in the MECP2 gene was identified in a boy with moderate intellectual disability, autism, and epilepsy. His mother carried the same MECP2 gene mutation, indicating potential genetic inheritance.
Area of Science:
- Genetics
- Neuroscience
- Pediatrics
Background:
- The MECP2 gene plays a crucial role in neurodevelopment.
- Mutations in MECP2 are associated with various neurodevelopmental disorders, including Rett syndrome.
- Understanding novel mutations is key to diagnosing and managing affected individuals.
Observation:
- A 6-year-old boy presented with moderate intellectual disability, autistic features, and epilepsy.
- Genetic analysis revealed a novel missense mutation (964C>T) in the MECP2 gene in the patient.
- The patient's mother was found to be heterozygous for the same MECP2 mutation.
Findings:
- The identified 964C>T mutation is a novel variant within the MECP2 gene.
- This mutation is associated with a clinical phenotype of moderate intellectual disability, autistic features, and epilepsy in the affected child.
- The heterozygous status in the mother suggests a possible inherited pattern for this MECP2 mutation.
Implications:
- This case expands the spectrum of known MECP2 mutations and their associated clinical presentations.
- Identifying novel MECP2 mutations aids in accurate genetic diagnosis and counseling for families.
- Further research into this specific mutation may elucidate MECP2 gene function and its role in neurodevelopmental disorders.
Abstract:
We describe the clinical and molecular findings of a 6-year-old boy carrying a novel missense 964C>T mutation on the MECP2 gene. The patient shows moderate mental retardation with autistic features and epilepsy. His mother is heterozygous for the same mutation.
